Wuhan Keqian Biology Co.,Ltd (SHA:688526)

China flag China · Delayed Price · Currency is CNY
15.05
-0.04 (-0.27%)
Apr 21, 2026, 3:00 PM CST
Market Cap6.98B +0.0%
Revenue (ttm)949.74M +0.8%
Net Income418.72M +9.5%
EPS0.90 +9.8%
Shares Out463.92M
PE Ratio16.72
Forward PE14.68
Dividend0.64 (4.24%)
Ex-Dividend DateJun 16, 2025
Volume1,160,978
Average Volume2,323,319
Open15.04
Previous Close15.09
Day's Range15.02 - 15.14
52-Week Range14.17 - 20.39
Beta0.59
RSI47.77
Earnings DateApr 8, 2026

About SHA:688526

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 922
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688526
Full Company Profile

Financial Performance

In 2025, SHA:688526's revenue was 949.74 million, an increase of 0.83% compared to the previous year's 941.92 million. Earnings were 418.72 million, an increase of 9.51%.

Financial Statements